Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Applied Materials has fallen another leg lower since Sunday's note, closing Tuesday at $464.24, down 12.5% on the week, and the question now is whether this is a sector-wide reset or something more specific to the stock.
The sector angle is hard to dismiss. Every close peer fell sharply on the week. LRCX dropped 9.8%, KLAC fell 6.8%, and smaller names took harder hits: UCTT lost 16.7%, ONTO dropped 16.0%, and fell 17.4%. AMAT's 12.5% decline sits roughly in the middle of that range. This is not a stock-specific breakdown. The whole semiconductor equipment group repriced this week, and Applied Materials moved with it.
What is notable is what short sellers are not doing. Short interest has actually eased 5.1% on the week to 1.67% of free float, continuing the retreat that last week's note described from the September peak above 2%. Borrow is almost frictionless: the cost to borrow is 0.32%, down 10% on the week, and availability is at its maximum ceiling reading. There is no meaningful short-side pressure in the lending market, and nothing in the positioning data suggests short sellers are driving the selloff.
Options tell a more defensive story. The put/call ratio has climbed to 1.41, above its 20-day average of 1.37 and approaching the 52-week high of 1.44. The z-score of 1.09 is not extreme, but the direction matters: options traders have been adding downside protection consistently through the second week of October, as the stock dropped through $500 and then through $480. That is cautious positioning, not panic.
The Street has not moved materially since Sunday. RBC Capital reiterated its Outperform rating with a $600 target on Tuesday. The consensus mean target is $635, which now implies 37% upside from the current price. Morgan Stanley, the one notable skeptic, cut its target from $642 to $563 in late September and holds an Equal-Weight rating. The bull case centres on AMAT's dominant position in deposition, its 3QFY26 revenue of $9.1bn, and 4Q guidance of $10.25bn well above consensus. The bear case keeps coming back to China, which is roughly 30% of revenue, and the potential for export controls or inventory corrections to erode that piece of the mix. Neither side has changed its argument this week. The ORTEX short score is 29.8, unchanged on the week, ranking in the 84th percentile for low short-side pressure.
One data point from the alt data layer adds a different shade. Wikipedia traffic, a proxy for retail attention, is running 2.0 standard deviations below AMAT's own 90-day average as of October 5. That reading captures the relative indifference of retail participants: after months of strong interest in a stock that was up nearly 100% year-to-date, attention has visibly faded as the price has come in. That is colour rather than a leading indicator, as the dataset has not been measured to lead the company's reported figures.
The earnings calendar provides the next hard anchor. Results are scheduled for November 12, 29 days out. After the August print the stock fell 7.5% the following day and 9.5% over the subsequent five sessions. Heading into November, the setup worth tracking is whether the options market, already more defensive than its recent average, continues to price in more downside protection as the quarter-close data comes into view.
See the live data behind this article on ORTEX.
Open AMAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
